217 related articles for article (PubMed ID: 33333147)
21. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
22. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men.
Nerpin E; Ingelsson E; Risérus U; Sundström J; Larsson A; Jobs E; Jobs M; Hallan S; Zethelius B; Berglund L; Basu S; Arnlöv J
Nephrol Dial Transplant; 2011 Sep; 26(9):2820-7. PubMed ID: 21335440
[TBL] [Abstract][Full Text] [Related]
23. Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Tomaschitz A; Pilz S; Ritz E; Grammer T; Drechsler C; Boehm BO; März W
Am J Kidney Dis; 2011 Mar; 57(3):403-14. PubMed ID: 21186074
[TBL] [Abstract][Full Text] [Related]
24. The Relation of Serum Potassium Concentration with Cardiovascular Events and Mortality in Community-Living Individuals.
Hughes-Austin JM; Rifkin DE; Beben T; Katz R; Sarnak MJ; Deo R; Hoofnagle AN; Homma S; Siscovick DS; Sotoodehnia N; Psaty BM; de Boer IH; Kestenbaum B; Shlipak MG; Ix JH
Clin J Am Soc Nephrol; 2017 Feb; 12(2):245-252. PubMed ID: 28143865
[TBL] [Abstract][Full Text] [Related]
25. Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.
Lee AK; Katz R; Jotwani V; Garimella PS; Ambrosius WT; Cheung AK; Gren LH; Neyra JA; Punzi H; Raphael KL; Shlipak MG; Ix JH
Hypertension; 2019 Oct; 74(4):872-879. PubMed ID: 31378102
[TBL] [Abstract][Full Text] [Related]
26. Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events.
Bress AP; Greene T; Derington CG; Shen J; Xu Y; Zhang Y; Ying J; Bellows BK; Cushman WC; Whelton PK; Pajewski NM; Reboussin D; Beddu S; Hess R; Herrick JS; Zhang Z; Kolm P; Yeh RW; Basu S; Weintraub WS; Moran AE;
J Am Coll Cardiol; 2021 Apr; 77(16):1977-1990. PubMed ID: 33888247
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants.
Bullen AL; Katz R; Jotwani V; Garimella PS; Lee AK; Estrella MM; Shlipak MG; Ix JH
Am J Kidney Dis; 2021 Sep; 78(3):361-368.e1. PubMed ID: 33857535
[TBL] [Abstract][Full Text] [Related]
28. Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Cohen JB; Yang W; Li L; Zhang X; Zheng Z; Orlandi P; Bansal N; Deo R; Lash JP; Rahman M; He J; Shafi T; Chen J; Cohen DL; Matsushita K; Shlipak MG; Wolf M; Go AS; Feldman HI;
Am J Kidney Dis; 2022 Jan; 79(1):36-44.e1. PubMed ID: 34052355
[TBL] [Abstract][Full Text] [Related]
29. Serious Adverse Events Cluster in Participants Experiencing the Primary Composite Cardiovascular Endpoint: A Post Hoc Analysis of the SPRINT Trial.
Botchway A; Buhnerkempe MG; Prakash V; Al-Akchar M; Adekola B; Flack JM
Am J Hypertens; 2020 May; 33(6):528-533. PubMed ID: 31930338
[TBL] [Abstract][Full Text] [Related]
30. Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy.
Vaduganathan M; Pareek M; Kristensen AMD; Biering-Sørensen T; Byrne C; Almarzooq Z; Olesen TB; Olsen MH; Bhatt DL
Eur J Heart Fail; 2021 Mar; 23(3):384-392. PubMed ID: 33448580
[TBL] [Abstract][Full Text] [Related]
31. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
[TBL] [Abstract][Full Text] [Related]
32. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
[TBL] [Abstract][Full Text] [Related]
33. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes.
Foster MC; Hwang SJ; Larson MG; Parikh NI; Meigs JB; Vasan RS; Wang TJ; Levy D; Fox CS
Arch Intern Med; 2007 Jul; 167(13):1386-92. PubMed ID: 17620532
[TBL] [Abstract][Full Text] [Related]
34. High risks of all-cause and cardiovascular deaths in apparently healthy middle-aged people with preserved glomerular filtration rate and albuminuria: A prospective cohort study.
Ohsawa M; Fujioka T; Ogasawara K; Tanno K; Okamura T; Turin TC; Itai K; Ogawa A; Yoshida Y; Omama S; Onoda T; Nakamura M; Makita S; Ishibashi Y; Tanaka F; Kuribayashi T; Ohta M; Sakata K; Okayama A
Int J Cardiol; 2013 Dec; 170(2):167-72. PubMed ID: 24211064
[TBL] [Abstract][Full Text] [Related]
35. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.
Clase CM; Gao P; Tobe SW; McQueen MJ; Grosshennig A; Teo KK; Yusuf S; Mann JF;
Ann Intern Med; 2011 Mar; 154(5):310-8. PubMed ID: 21357908
[TBL] [Abstract][Full Text] [Related]
36. Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up.
Nagai K; Sairenchi T; Irie F; Watanabe H; Ota H; Yamagata K
PLoS One; 2016; 11(6):e0156792. PubMed ID: 27272675
[TBL] [Abstract][Full Text] [Related]
37. CVD risk in non-albuminuric chronic kidney disease in hypertensive, non-diabetic subjects: A
Sheng CS; Wang D; Yuan J; Cheng Y; Sun S; Yang Y; Miao Y; Wang W; Tian J; Bloomgarden ZT
Front Cardiovasc Med; 2022; 9():977938. PubMed ID: 36568559
[TBL] [Abstract][Full Text] [Related]
38. GFR Variability, Survival, and Cardiovascular Events in Older Adults.
Fravel MA; Ernst ME; Webb KL; Wetmore JB; Wolfe R; Woods RL; Reid CM; Chowdhury E; Murray AM; Polkinghorne KR;
Kidney Med; 2023 Feb; 5(2):100583. PubMed ID: 36794000
[TBL] [Abstract][Full Text] [Related]
39. Estimated glomerular filtration rate, all-cause mortality and cardiovascular diseases incidence in a low risk population: the MATISS study.
Donfrancesco C; Palleschi S; Palmieri L; Rossi B; Lo Noce C; Pannozzo F; Spoto B; Tripepi G; Zoccali C; Giampaoli S
PLoS One; 2013; 8(10):e78475. PubMed ID: 24147135
[TBL] [Abstract][Full Text] [Related]
40. Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study.
Hashemi A; Nourbakhsh S; Asgari S; Mirbolouk M; Azizi F; Hadaegh F
J Transl Med; 2018 Aug; 16(1):230. PubMed ID: 30111315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
